Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications

Authors
Poulter, NR Chang, CL Farley, TMM Meirik, O
Citation
Nr. Poulter et al., Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications, LANCET, 354(9190), 1999, pp. 1610-1610
Citations number
5
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
354
Issue
9190
Year of publication
1999
Pages
1610 - 1610
Database
ISI
SICI code
0140-6736(19991106)354:9190<1610:ROCDAW>2.0.ZU;2-5
Abstract
Data from the WHO Collaborative Study suggest that use of progestagen prepa rations with therapeutic indications are associated with a significantly in creased risk of venous thromboembolism but not stroke or myocardial infarct ion.